Search research articles
Contact Us
Filters
Showing results (151-160 of 184) with videos related to
Page
of 19
Sort By:
Photochemistry and Photobiology
|
February 6, 2008
Cross-validation of murine UV signal transduction pathways in human skin
Janine G Einspahr, G Timothy Bowden, David S Alberts, et al.
Gynecologic Oncology
|
December 8, 2004
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study
Mace L Rothenberg, P Y Liu, Sharon Wilczynski, et al.
Gynecologic Oncology
|
October 13, 2015
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study
Lisa M Hess, Helen Q Huang, Alexandra L Hanlon, et al.
Seminars in Oncology
|
February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials
David S Alberts, Franco M Muggia, James Carmichael, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 25, 2019
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study
Gustavo C Rodriguez, James Kauderer, Jessica Hunn, et al.
Journal of Biomedical Optics
|
July 3, 2021
Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes
Ricky Cordova, Kelli Kiekens, Susan Burrell, et al.
British Journal of Cancer
|
July 1, 2017
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers
Maria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
Journal of the National Cancer Institute
|
September 22, 2005
MGMT promoter methylation and field defect in sporadic colorectal cancer
Lanlan Shen, Yutaka Kondo, Gary L Rosner, et al.
Journal of the National Cancer Institute
|
June 2, 2005
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
David S Alberts, María Elena Martínez, Lisa M Hess, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 6, 2012
Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma
Janine G Einspahr, Valerie Calvert, David S Alberts, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 184) with videos related to
Sort By:
Page
of 19
Photochemistry and Photobiology
|
February 6, 2008
Cross-validation of murine UV signal transduction pathways in human skin
Janine G Einspahr, G Timothy Bowden, David S Alberts, et al.
Gynecologic Oncology
|
December 8, 2004
Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study
Mace L Rothenberg, P Y Liu, Sharon Wilczynski, et al.
Gynecologic Oncology
|
October 13, 2015
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study
Lisa M Hess, Helen Q Huang, Alexandra L Hanlon, et al.
Seminars in Oncology
|
February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials
David S Alberts, Franco M Muggia, James Carmichael, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
April 25, 2019
Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study
Gustavo C Rodriguez, James Kauderer, Jessica Hunn, et al.
Journal of Biomedical Optics
|
July 3, 2021
Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes
Ricky Cordova, Kelli Kiekens, Susan Burrell, et al.
British Journal of Cancer
|
July 1, 2017
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers
Maria Isabella Sereni, Elisa Baldelli, Guido Gambara, et al.
Journal of the National Cancer Institute
|
September 22, 2005
MGMT promoter methylation and field defect in sporadic colorectal cancer
Lanlan Shen, Yutaka Kondo, Gary L Rosner, et al.
Journal of the National Cancer Institute
|
June 2, 2005
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
David S Alberts, María Elena Martínez, Lisa M Hess, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 6, 2012
Functional protein pathway activation mapping of the progression of normal skin to squamous cell carcinoma
Janine G Einspahr, Valerie Calvert, David S Alberts, et al.
Page
of 19